Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (21 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Net sales
747
1,128
1,415
1,525
1,740
1,074
Cost of sales
533
766
952
1,050
1,180
811
Gross Profit
214
362
463
475
559
263
Selling, general and administrative expenses
-141
-187
225
270
313
265
Contingent consideration (benefit)
0
-12
-5
0
0
0
Goodwill and Intangible Asset Impairment
0
0
1
0
0
125
Transaction expenses
0
-4
2
3
2
0
Loss on sale of assets
0
1
-1
1
1
1
Total operating expenses
141
202
222
273
317
391
Earnings from equity investment
0
0
0
7
25
15
Operating income (loss)
73
161
241
210
268
-114
Expenses related to the Combination
7
0
0
0
0
0
Interest expense
18
20
16
18
30
30
Foreign exchange (gains) losses and other, net
-2
0
2
3
-4
-9
Deferred loan costs written off
6
0
0
2
0
0
Total other expense
29
20
18
23
26
21
INCOME (LOSS) BEFORE INCOME TAXES
44
141
223
186
243
-134
Provision for income tax expense (benefit)
20
47
71
56
68
-15
Net Income (Loss)
24
94
152
130
174
-119
Less: Income (loss) attributable to noncontrolling interest
0
0
0
0
0
0
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS
24
93
151
130
174
-119
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (39 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
21
41
40
77
109
Accounts receivable—trade, net
n/a
229
229
250
287
139
Inventories, net
n/a
325
455
441
462
424
Prepaid expenses and other current assets
n/a
14
13
30
33
34
Costs and estimated profits in excess of billings
n/a
12
7
24
15
12
Deferred income taxes, net
n/a
19
30
25
22
0
Total current assets
n/a
619
775
809
895
718
Property and equipment, net of accumulated depreciation
n/a
125
153
180
190
187
Deferred financing costs, net
n/a
10
8
16
6
4
Intangibles, net
n/a
241
257
295
272
247
Goodwill
n/a
601
696
802
798
669
Investment in unconsolidated subsidiary
n/a
0
0
60
50
58
Deferred income taxes, net
n/a
0
0
0
0
1
Other long-term assets
n/a
12
4
5
3
3
Total assets
n/a
1,607
1,893
2,169
2,214
1,886
Liabilities and owners' equity
Current portion of long-term debt
n/a
5 5176000
21 20504000
1 998000
1 840000
0 253000
Accounts payable—trade
n/a
98 97642000
99 98990000
100 100221000
128 127757000
77 76823000
Accrued liabilities
n/a
92 92251000
86 85893000
97 96529000
127 126890000
59 58563000
Contingent consideration liability
n/a
42 41800000
16 15664000
0 0
0 0
0 0
Deferred revenue
n/a
13 12692000
34 33720000
16 15837000
11 10919000
7 7283000
Billings in excess of costs and profits recognized
n/a
5 4906000
18 17582000
6 6398000
16 15785000
9 8631000
Derivative instruments
n/a
0 185000
1 714000
0 0
0 0
0 0
Total current liabilities
n/a
255 254652000
273 273067000
220 219983000
282 282191000
152 151553000
Long-term debt, net of current portion
n/a
660 660379000
400 400201000
512 512077000
420 420484000
396 396016000
Deferred income taxes, net
n/a
35 35103000
58 57557000
98 97774000
98 98188000
51 51100000
Derivative instruments
n/a
2 1588000
0 0
0 0
0 0
0 0
Other long-term liabilities
n/a
0 461000
0 0
8 8069000
17 17318000
30 29956000
Total liabilities
n/a
952 952183000
731 730825000
838 837903000
818 818181000
629 628625000
Commitments and contingencies
n/a
0 0
0 0
0 0
0 0
0 0
Common stock, $0.01 par value
n/a
1 679000
1 875000
1 964000
1 979000
1 986000
Additional paid-in capital
n/a
424 424466000
765 764635000
826 826028000
864 864313000
891 891248000
Treasury stock at cost
n/a
-26 -25877000
-26 -25933000
-30 -30249000
-132 -132480000
-133 -133318000
Warrants
n/a
27 27097000
26 26394000
1 687000
0 0
0 0
Retained earnings
n/a
244 244145000
396 395601000
525 525140000
700 699505000
580 580152000
Accumulated other comprehensive loss
n/a
-16 -16017000
0 -100000
8 7785000
-37 -36961000
-82 -82048000
Total stockholders’ equity
n/a
654 654493000
1,161 1161472000
1,330 1330355000
1,395 1395356000
1,257 1257020000
Noncontrolling interest in subsidiary
n/a
1 639000
1 683000
1 611000
1 565000
0 397000
Total equity
n/a
655 655132000
1,162 1162155000
1,331 1330966000
1,396 1395921000
1,257 1257417000
Total liabilities and equity
n/a
1,607 1607315000
1,893 1892980000
2,169 2168869000
2,214 2214102000
1,886 1886042000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Feb 28, 2014 n/a restated on Feb 27, 2015 n/a restated on Feb 29, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (45 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Net Income (Loss)
24
94
152
130
174
-119
Depreciation expense
22
26
31
36
37
38
Amortization of intangible assets
11
15
20
24
28
27
Goodwill and Intangible Asset Impairment
0
0
0
0
0
125
Inventory reserves
0
0
0
10
8
52
Share-based compensation expense
5
5
8
19
19
22
Earnings from equity investment, net of distributions
0
0
0
-1
1
-8
Payment of contingent consideration included in operating expense
0
0
-7
0
0
0
Change in Contingent Consideration
0
12
-5
0
0
0
Impairment of intangible assets
0
0
1
0
0
0
Deferred income taxes
-1
-1
-6
16
-3
-23
Deferred loan costs written off
6
0
0
2
0
0
Provision for doubtful accounts
0
0
0
3
2
4
Other
3
4
2
-2
4
4
Accounts receivable—trade
-13
-62
13
1
-45
146
Inventories
-6
-91
-100
23
-34
0
Prepaid expenses and other current assets
2
-10
16
-20
-4
4
Cost and estimated profit in excess of billings
3
-5
5
-17
9
2
Accounts payable, deferred revenue and other accrued liabilities
14
56
-5
-1
63
-111
Billings in excess of costs and estimated profits earned
-4
-3
12
-11
10
-7
Net cash provided by operating activities
66
39
138
211
270
156
Acquisition of businesses, net of cash acquired
0
-510
-140
-182
-38
-61
Investment in unconsolidated subsidiary
0
0
0
-112
0
0
Distribution from unconsolidated subsidiary
0
0
0
64
0
0
Capital expenditures for property and equipment
-20
-41
-50
-60
-54
-32
Return of investment in unconsolidated subsidiary
0
0
0
0
9
0
Proceeds from sale of business, property and equipment
1
1
5
1
12
2
Capitalized costs related to patents
0
0
0
0
0
0
Net cash used in investing activities
-19
-550
-185
-289
-71
-91
Borrowings of long term and short term debt
324
10
0
403
0
0
Repayment of long term and short term debt
-407
-62
-454
-715
-98
-120
Borrowings under credit facility
0
510
203
405
15
95
Proceeds of IPO, net of offering costs
0
0
256
0
0
0
Proceeds from concurrent private placement
0
0
50
0
0
0
Payment of contingent consideration accrued at acquisition
0
0
-11
-11
0
0
Purchased stock due to the Combination
-3
0
0
0
0
0
Repurchases of stock
-25
0
0
-4
-97
-6
Excess tax benefits from stock based compensation
0
1
7
7
8
0
Proceeds from stock issuance
65
57
14
5
11
5
Payment of capital lease obligation
-1
0
0
-1
-1
-1
Deferred financing costs
-7
-6
0
-12
0
0
Net cash provided by (used in) financing activities
-54
510
66
77
-162
-27
Effect of exchange rate changes on cash
1
1
1
-1
0
-5
Net increase (decrease) in cash and cash equivalents
-7
0
21
-1
37
33
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,